Matosevic Lab (@matoseviclab) header
Matosevic Lab (@matoseviclab) profile picture

Cancer immunotherapy lab at Purdue University. Natural killer cells, CAR-NK, immunology, tumor microenvironment, solid tumors.

West Lafayette, IN, USA
Joined June 2020
Photo by Matosevic Lab (@matoseviclab)Photo by Matosevic Lab (@matoseviclab)Photo by Matosevic Lab (@matoseviclab)Photo by Matosevic Lab (@matoseviclab)Photo by Matosevic Lab (@matoseviclab)Photo by Matosevic Lab (@matoseviclab)Photo by Matosevic Lab (@matoseviclab)Photo by Matosevic Lab (@matoseviclab)Photo by Matosevic Lab (@matoseviclab)Photo by Matosevic Lab (@matoseviclab)
#ScienceSaturday Treating #neurological disorders like #brain tumors is difficult in part due to a protective “wall” called the blood-brain barrier, meant to block toxins from reaching brain cells. ➡️ In this study, @DrMilosSimic, @NishRReddy, Et al. developed brain-sensing T cells, engineered to deliver brain tumor-specific chimeric antigen receptors upon sensing the brain tumor microenvironment. ➡️ This approach could pave the way for safer and more effective treatments for diseases like brain tumors, brain metastases, neuro-inflammation and more. 🔗 Here's a link to the full article: science.org/doi/10.1126/scie…
1
16
1
30
3,919
Matosevic Lab retweeted
Could one envision a synthetic receptor technology that is fully programmable, able to detect diverse extracellular antigens – both soluble and cell-attached – and convert that recognition into a wide range of intracellular responses, from transgene expression and real-time fluorescence to modulation of innate cell behavior (excitation or inhibition of neurons, induction of cell migration, etc.)? Today we report in Nature a new technology platform that provides a step in that direction: PAGERs, for Programmable Antigen-gated G protein-coupled Engineered Receptors, convert recognition of extracellular soluble or cell-attached antigens into diverse user-selected responses. PAGERs are based on G-protein coupled receptors (GPCRs), which themselves are not structurally modular, but we were able to build in modular antigen gating by fusing an antagonist peptide to the extracellular N-terminal end, and then gating the antagonist with a fused antigen-binding nanobody.  When antigen binds, it sterically interferes with the antagonist, leading to relief of receptor inhibition. Drug or agonist can then turn on PAGER. nature.com/articles/s41586-0…
61
247
23
951
125,600
Matosevic Lab retweeted
I’m excited to share our latest study in @nature on this novel compound called Gliocidin, that targets glioblastoma (#GBM), the most malignant brain tumor. #drugdiscovery #cancer #cancermetabolism @GSKGradSchool @MSKCancerCenter nature.com/articles/s41586-0…
16
80
11
415
46,264
#CARTcells for #DIPG #DMG clinical trial (1st arm) results are out today. Full Tweetorial coming, but first want to share the story of a patient whose #DIPG has disappeared for over 3 years. It is a milestone and moment of hope on a journey filled with so much grief. “There’s a lot of loss that led to this research,” Drew’s dad said. “I hope those families know that this success is because of them.” med.stanford.edu/news/all-ne…
30
157
29
613
105,860
1/ This is the next chapter of a story about courageous patients and their families, of multidisciplinary teamwork, and hard-fought steps forward to effective therapy for #DIPG #DMG, a universally lethal cancer of the brain and spinal cord. 🧵nature.com/articles/s41586-0…
21
145
27
519
113,751
Incredible to be in the north hills of Croatia to speak about immune cell modulation and immunotherapy at @SiC_2022 courtesy of the Croatian Chemical Society. Hope it’s the first of more trips back! #croatia
1
166
Matosevic Lab retweeted
Published today @NatureBiotech: @CarlHJune and I reveal how CAR T cells are finally tackling solid tumors! @PennPPA @PennMDForum nature.com/articles/s41587-0…
14
118
8
488
126,588
In Seattle, checking out the Echo Olympic sculpture watching a beautiful sunset
1
118
Matosevic Lab retweeted
Thank you for highlighting our new approach to cancer immunotherapy using non pathogenic bacteria to surface display and deliver biologics to TME.. Eager to evaluate it in the clinic. Collaboration with Prof Jiahe Li’s group at @UMich @DanaFarber @Romee_Lab @NatureBiotech
How do we increase anti-tumor responses? Researchers in the @Romee_Lab delivered key immune-activating cytokines to tumors using E. coli. 🦠 "This is a brand new modality of immunotherapy," says Dr. Rizwan Romee (@romeerizwan). 🔎 Read the Q&A: bit.ly/3YiNizA
1
6
1
54
5,710
Back at Roswell Park for the MSC Symposium on Cancer Research and Care — great science and great sunsets! @roswellpark
5
242
So proud of Dr. Yao for graduating with a PhD from Purdue. We are already missing you in the lab but I’m so excited for everything ahead for you! Huge, deserved congratulations
1
242
Matosevic Lab retweeted
🙌🧬It’s official: the first TCR gene therapy for the treatment of cancer received @US_FDA approval this evening. A milestone event for the oncology community and the 2nd cell therapy approved for solid cancers! @Adaptimmune #Tcellpower adaptimmune.com/investors-an…
4
44
4
153
16,221
Proud of Purdue Summer Undergraduate Research Fellowship student Drake for a great presentation of his new research project. It was absolutely great having him in the lab for the past few weeks as a SURF student! @PurdueEngineers
1
4
399
Matosevic Lab retweeted
Thrilled to announce the publication of our latest research in Nature Immunology. Joining forces with 20 laboratories in Europe and USA, we identified the three prominent NK cell subsets in human: NK1, NK2, and NK3: rdcu.be/dMuAs
15
46
11
218
46,954
Matosevic Lab retweeted
The phrase ‘metastasis accounts for 90% of cancer deaths’ is one of the most widely used in cancer research, yet it is overly simplistic & imprecise. Here we dig deeper into the events leading to cancer mortality nature.com/articles/s41568-0… 1/2
12
88
7
295
35,730
Matosevic Lab retweeted
Second tumors after CAR T-cell therapy are rare, and in one case of a secondary T-cell lymphoma, detailed analysis showed that the genetic construct that was used to make the CAR T cells was unrelated to the second tumor. Read the full study results: nej.md/3Rln392
1
111
4
300
48,875
Have enjoyed speaking about cryopreservation of NK cells at the ISOPOW symposium today, hosted right here on the Purdue campus
1
5
260
According to @theABTA, 90,000 people are diagnosed with a brain tumor every year. June 8 marks #WorldBrainTumorDay, and @LifeAtPurdue researchers are genetically engineering a treatment for incurable brain tumors. Read more about their efforts: bit.ly/3R81Dfg
2
6
488